Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-09

Clinical Trial Update: Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial update assessing a contact dermatitis model to study skin inflammation using biologic medications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wei-Che Ko | Conditions: Skin Inflammation, Allergic Contact Dermatitis | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING